Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > What’s going on?

<< Previous

Bullboard Posts

Next >>

Comment by jimmyhorizonon Sep 27, 2022 5:04am

130 Views

Post# 34988588

RE:RE:RE:RE:RE:RE:RE:RE:What’s going on?

ok. then call it a small sale or insignificant volume.

the observation is: yesterday evening (german time) over 400k in the ask in CAN. this morning it goes in germany from 8:03 to 8:22 with 128.999 pieces by 14% to the south.

And this two days before the secret of the upfront of our blockbuster deal is published, which turns sirona into a profitable company. in the week in which more news will be published. such movements have also happened in the past.

and they were never good. why should they be? something like this was talked up with shaking the tree.

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland